Feller Faye 4
4 · GERON CORP · Filed Sep 21, 2023
Insider Transaction Report
Form 4
GERON CORPGERN
Feller Faye
EVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-08-15+20,000→ 20,000 totalExercise: $1.06From: 2023-08-15Exp: 2032-02-15→ Common Stock (20,000 underlying) - Award
Employee Stock Option (right to buy)
2023-08-15+180,000→ 180,000 totalExercise: $1.93From: 2023-08-15Exp: 2032-07-07→ Common Stock (180,000 underlying)
Footnotes (2)
- [F1]Performance-based stock option granted on February 16, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.
- [F2]Performance-based stock option granted on July 8, 2022 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.